Article
A Digital Twin of Glimepiride for Personalized and Stratified Diabetes Treatment
2025-06-17
Abstract excerpt
Optimizing glimepiride therapy for type 2 diabetes (T2DM) is challenged by pronounced inter-individual variability in pharmacokinetics. To address this, we developed a whole-body physiologically based pharmacokinetic (PBPK) model as a digital twin of glimepiride. This model enables systematic evaluation of how patient-specific factors influence glimepiride disposition, supporting both personalized and stratified t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a9c7fc31-afe1-5a8c-9ca4-c866d4b2424c
- DOI
- 10.20944/preprints202506.1264.v1
